Monari F - Search Results

1

Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report.

Rizzini EL, Ghedini P, Cardano R, Bellarosa C, Morganti AG, Fanti S, Monari F. Rizzini EL, et al. Among authors: monari f. Mol Clin Oncol. 2019 Jul;11(1):63-66. doi: 10.3892/mco.2019.1852. Epub 2019 May 6. Mol Clin Oncol. 2019. PMID: 31289680 Free PMC article.

2

Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.

Pettinato C, Monari F, Nanni C, Allegri V, Marcatili S, Civollani S, Cima S, Spezi E, Mazzarotto R, Fanti S. Pettinato C, et al. Among authors: monari f. Q J Nucl Med Mol Imaging. 2012 Dec;56(6):509-14. Q J Nucl Med Mol Imaging. 2012. PMID: 23358403 Free article. Clinical Trial.

3

Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning.

Pettinato C, Spezi E, Nanni C, Grassetto G, Monari F, Allegri V, Civollani S, Cima S, Zagni P, Mazzarotto R, Colletti PM, Rubello D, Fanti S. Pettinato C, et al. Among authors: monari f. Clin Nucl Med. 2014 Aug;39(8):e367-74. doi: 10.1097/RLU.0000000000000490. Clin Nucl Med. 2014. PMID: 24978332

4

Complete pathological response after chemo-radiation in anaplastic thyroid cancer: A report of two cases.

Zanirato Rambaldi G, Monari F, Fiorentino M, Cammelli S, Repaci A, Cremonini N, Cavicchi O, Caliceti U, Farina E, Deodato F, Di Fabio F, Presutti L, Fanti S, Frezza GP, Morganti AG. Zanirato Rambaldi G, et al. Among authors: monari f. Acta Oncol. 2016;55(4):530-2. doi: 10.3109/0284186X.2015.1102966. Epub 2015 Nov 2. Acta Oncol. 2016. PMID: 26523660 No abstract available.

5

Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review.

Farina E, Monari F, Tallini G, Repaci A, Mazzarotto R, Giunchi F, Panzacchi R, Cammelli S, Padula GD, Deodato F, Pasquali R, Fanti S, Fiorentino M, Morganti AG. Farina E, et al. Among authors: monari f. Endocr Pathol. 2016 Mar;27(1):55-64. doi: 10.1007/s12022-015-9410-7. Endocr Pathol. 2016. PMID: 26662609 Review.

6

¹⁸F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study.

Farina E, Monari F, Castellucci P, Romani F, Repaci A, Farina A, Zanirato Rambaldi G, Frezza G, Mazzarotto R, Cammelli S, Tagliaferri L, Autorino R, Deodato F, Macchia G, Cilla S, Valentini V, Fanti S, Morganti AG. Farina E, et al. Among authors: monari f. J Thyroid Res. 2017;2017:9807543. doi: 10.1155/2017/9807543. Epub 2017 Oct 19. J Thyroid Res. 2017. PMID: 29201490 Free PMC article.

7

²²³Ra-chloride therapy in men with hormone-refractory prostate cancer and skeletal metastases: Real-world experience.

Boni G, Mazzarri S, Cianci C, Galli L, Farnesi A, Borsatti E, Bortolus R, Fratino L, Gobitti C, Lamaj E, Ghedini P, Rizzini EL, Massari F, Dionisi V, Fanti S, Volterrani D, Monari F. Boni G, et al. Among authors: monari f. Tumori. 2018 Mar-Apr;104(2):128-136. doi: 10.1177/0300891618765571. Epub 2018 Apr 18. Tumori. 2018. PMID: 29714668

8

Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care.

De Vincentis G, Monari F, Baldari S, Salgarello M, Frantellizzi V, Salvi E, Reale L, Napolitano S, Conti G, Cortesi E. De Vincentis G, et al. Among authors: monari f. Future Oncol. 2018 Nov;14(27):2821-2832. doi: 10.2217/fon-2018-0318. Epub 2018 Jun 15. Future Oncol. 2018. PMID: 29905090 Free article.

9

Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases.

Dionisi V, Bellarosa C, Cardano R, Rizzini EL, Ghedini P, Morganti AG, Fanti S, Monari F. Dionisi V, et al. Among authors: monari f. Clin Genitourin Cancer. 2019 Jun;17(3):e612-e617. doi: 10.1016/j.clgc.2019.03.002. Epub 2019 Mar 13. Clin Genitourin Cancer. 2019. PMID: 30956096 Free article. No abstract available.

10

Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.

Caffo O, Frantellizzi V, Tucci M, Galli L, Monari F, Baldari S, Masini C, Bortolus R, Facchini G, Alongi P, Agostini S, Zichi C, Biasco E, Fanti S, Pignata S, Filice A, Borsatti E, Rossetti S, Spada M, Cortesi E, De Vincentis G. Caffo O, et al. Among authors: monari f. Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2633-2638. doi: 10.1007/s00259-020-04796-w. Epub 2020 Apr 5. Eur J Nucl Med Mol Imaging. 2020. PMID: 32249345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page